Which ophthalmic ointment should be prescribed for a skilled‑nursing‑facility resident with eyelid dermatitis, using a low‑potency topical steroid?

Ophthalmic Ointment for Eyelid Dermatitis in Skilled Nursing Facility Residents

For eyelid dermatitis in a skilled nursing facility resident, prescribe a low-potency topical corticosteroid ointment such as fluorometholone phosphate or loteprednol etabonate, applied several times daily to the eyelids, with close monitoring for intraocular pressure elevation. 1

Rationale for Low-Potency Corticosteroid Selection

The 2024 Ophthalmology guidelines specifically recommend using corticosteroids with limited ocular penetration to minimize adverse effects when treating eyelid inflammation. 1 The two preferred agents are:

• Fluorometholone phosphate - has limited ocular penetration and lower risk of IOP elevation 1
• Loteprednol etabonate - a site-specific corticosteroid that minimizes systemic and intraocular adverse effects 1

Application Protocol

Apply the corticosteroid ointment several times daily directly to the affected eyelids. 1 Once inflammation is controlled:

• Taper the corticosteroid gradually 1
• Discontinue when possible 1
• Use intermittently only as needed to maintain comfort 1
• Always use the minimal effective dose 1

Critical Safety Monitoring

Patients must be informed of potential adverse effects, particularly increased intraocular pressure and cataract formation. 1 However, the evidence regarding these risks with eyelid application is nuanced:

• Topical corticosteroids applied to eyelids may increase risk of IOP elevation (RR 5.96) compared to lubricants 2
• One study found no glaucoma cases and only 2 corticosteroid-induced cataracts (both likely from systemic steroids) in 88 atopic dermatitis patients using topical steroids on eyelids 3
• Application to eyelids over longer periods was not related to glaucoma or cataracts in this cohort 3
• The risk appears highest with potent corticosteroids used inappropriately for prolonged periods 4

Alternative Consideration: Tacrolimus

If corticosteroid use is contraindicated or fails, tacrolimus 0.1% ointment is a promising alternative. 5 A 2007 crossover study demonstrated:

• Near superior benefit for tacrolimus versus clobetasone butyrate 0.05% in reducing eyelid eczema signs (P=0.05) 5
• No evident effect on intraocular pressure with either treatment 5
• Effective in reducing both signs and symptoms of eyelid eczema 5

Tacrolimus can also be combined with oral azithromycin for enhanced effect in certain cases. 1

Common Pitfalls to Avoid

Do not use long-term corticosteroid therapy without clear justification and monitoring. 1 Key considerations:

• Avoid prolonged continuous use - taper and discontinue when inflammation resolves 1
• Do not use high-potency corticosteroids on eyelids - stick to low-potency formulations with limited ocular penetration 1, 4
• Consider that the dermatitis may be allergic contact dermatitis from eye drops (54.2% of cases), creams/lotions (24.6%), or cosmetics (13.1%) 6
• Identification and elimination of causative agents is essential for definitive management 6

Duration and Follow-up

Limit initial treatment to a brief course (typically 3 weeks or less based on trial data), then reassess. 5, 2 Most trials evaluating topical steroids for ocular surface conditions used short durations (3-8 weeks) due to safety concerns. 2